Targeting the differentiation of astrocytes by Bilobalide in the treatment of Parkinson’s disease model

References

• Dahodwala N, Li P, Jahnke J, et al. Burden of Parkinson’s disease by severity: health care costs in the U.S. Medicare Population. Mov Disord. 2021;36(1):133–142.
   PubMed Web of Science ®Google Scholar
• Wilkaniec A, Lenkiewicz AM, Babiec L, et al. Exogenous alpha-Synuclein evoked Parkin downregulation promotes mitochondrial dysfunction in neuronal cells. Implications for Parkinson’s disease pathology. Front Aging Neurosci. 2021;13:591475.
   PubMed Web of Science ®Google Scholar
• Marogianni C, Sokratous M, Dardiotis E, et al. Neurodegeneration and inflammation-an interesting interplay in Parkinson’s disease. IJMS. 2020;21(22):8421.
   Web of Science ®Google Scholar
• Prasuhn J, Davis RL, Kumar KR. Targeting mitochondrial impairment in Parkinson’s disease: challenges and opportunities. Front Cell Dev Biol. 2020;8:615461.
   PubMed Web of Science ®Google Scholar
• Hemmati-Dinarvand M, Saedi S, Valilo M, et al. Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems. Neurosci Lett. 2019;709:134296.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Wong YC, Ysselstein D, et al. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci. 2019;42(2):140–149.
   PubMed Web of Science ®Google Scholar
• Cerri S, Blandini F. Role of autophagy in Parkinson’s disease. Curr Med Chem. 2019;26(20):3702–3718.
   PubMed Web of Science ®Google Scholar
• Perinan MT, Gómez-Garre P, Blauwendraat C, International Parkinson’s Disease Genomics Consortium (IPDGC), et al. The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset. Neurobiol Aging. 2021;97:144.e1–144.e3.
   PubMed Web of Science ®Google Scholar
• Elkouzi A, Vedam-Mai V, Eisinger RS, et al. Emerging therapies in Parkinson disease-repurposed drugs and new approaches. Nat Rev Neurol. 2019;15(4):204–223.
   PubMed Web of Science ®Google Scholar
• Tanmay T, Vatsal S. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr Stem Cell Res Ther. 2014;9(6):513–521.
   PubMed Web of Science ®Google Scholar
• Susanne G, Jessica S, Patrick K, et al. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev. 2008;17(2):221–232.
   PubMed Web of Science ®Google Scholar
• Mammadova N, Summers CM, Kokemuller RD, et al. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson’s disease. Neurobiol Dis. 2019;121:1–16.
   PubMed Web of Science ®Google Scholar
• Parvez MK. Natural or plant products for the treatment of neurological disorders: current knowledge. Curr Drug Metab. 2018;19(5):424–428.
   PubMed Web of Science ®Google Scholar
• Oppedisano F, Maiuolo J, Gliozzi M, et al. The potential for natural antioxidant supplementation in the early stages of neurodegenerative disorders. IJMS. 2020;21(7):2618.
   Web of Science ®Google Scholar
• Singh SK, Srivastav S, Castellani RJ, et al. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16(3):666–674.
   PubMed Web of Science ®Google Scholar
• Yang H, Li GP, Liu Q, et al. Neuroprotective effects of ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of epidermal growth factor receptor. Phytother Res. 2021;35(5):2727–2744.
   PubMed Web of Science ®Google Scholar
• Li ZY, Chung YH, Shin EJ, et al. YY-1224, a terpene trilactone-strengthened ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2. J Neuroinflammation. 2017;14(1):94.
   PubMed Web of Science ®Google Scholar
• Wu R, Shui L, Wang S, et al. Bilobalide alleviates depression-like behavior and cognitive deficit induced by chronic unpredictable mild stress in mice. Behav Pharmacol. 2016;27(7):596–605.
   PubMed Web of Science ®Google Scholar
• Ren C, Ji YQ, Liu H, et al. Effects of ginkgo biloba extract EGb761 on neural differentiation of stem cells offer new hope for neurological disease treatment. Neural Regen Res. 2019;14(7):1152–1157.
   PubMed Web of Science ®Google Scholar
• Cao A, Li X. Bilobalide protects H9c2 cell from oxygen-glucose-deprivation-caused damage through upregulation of miR-27a. Artif Cells Nanomed Biotechnol. 2019;47(1):2980–2988.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy A, Sevanan M, Mani S, et al. Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson’s disease mouse model. Neurosci Lett. 2019;709:134382.
   PubMed Web of Science ®Google Scholar
• Wang DX, Yang Y, Huang XS, et al. Pramipexole attenuates neuronal injury in Parkinson’s disease by targeting miR-96 to activate BNIP3-mediated mitophagy. Neurochem Int. 2021;146:104972.
   PubMed Web of Science ®Google Scholar
• Connell JW, Allison R, Reid E. Quantitative gait analysis using a motorized treadmill system sensitively detects motor abnormalities in mice expressing ATPase defective spastin. PLoS One. 2016;11(3):e0152413.
   PubMedGoogle Scholar
• Joers V, Tansey MG, Mulas G, et al. Microglial phenotypes in Parkinson’s disease and animal models of the disease. Prog Neurobiol. 2017;155:57–75.
   PubMed Web of Science ®Google Scholar
• David S, Kroner S. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12(7):388–399.
   PubMed Web of Science ®Google Scholar
• Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun. 2012;26(8):1191–1201.
   PubMed Web of Science ®Google Scholar
• Ar Rochmah M, Harini IM, Septyaningtrias DE, et al. Centella asiatica prevents increase of hippocampal tumor necrosis factor-alpha independently of its effect on brain-derived neurotrophic factor in rat model of chronic stress. Biomed Res Int. 2019;2019:2649281.
   PubMed Web of Science ®Google Scholar
• Kramer ER, Liss B. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 2015;589(24 Pt A):3760–3772.
   PubMed Web of Science ®Google Scholar
• Ferrini F, De Koninck Y. Microglia control neuronal network excitability via BDNF signalling. Neural Plast. 2013;2013:429815.
   PubMed Web of Science ®Google Scholar
• Hu E, Du H, Zhu X, et al. Beta-hydroxybutyrate promotes the expression of BDNF in hippocampal neurons under adequate glucose supply. Neuroscience. 2018;380:315–325.
   Web of Science ®Google Scholar
• Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596–1609.
   PubMed Web of Science ®Google Scholar
• Rietdijk CD, van Weze RJA, Garssen J, et al. Neuronal toll-like receptors and neuro-immunity in Parkinson’s disease, alzheimer’s disease and stroke. NN. 2016;3(2):27–37.
   Google Scholar
• Azam S, Jakaria M, Kim IS, et al. Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative ­diseases: focus on TLR4 signaling. Front Immunol. 2019;10:1000.
   PubMed Web of Science ®Google Scholar
• Filippov V, Kronenberg G, Pivneva T, et al. Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocyte. Mol Cell Neurosci. 2003;23(3):373–382.
   PubMed Web of Science ®Google Scholar
• Eliasson C, Sahlgren C, Berthold CH, et al. Intermediate filament protein partnership in astrocytes. J Biol Chem. 1999;274(34):23996–24006.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhou W, Jin H, et al. Brn2 alone is sufficient to convert astrocytes into neural progenitors and neurons. Stem Cells Dev. 2018;27(11):736–744.
   PubMed Web of Science ®Google Scholar
• Ma K, Deng X, Xia X, et al. Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons. Transl Neurodegener. 2018;7:29.
   PubMed Web of Science ®Google Scholar
• Le WD, Rowe DB, Jankovic J, et al. Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch Neurol. 1999;56(2):194–200.
   PubMedGoogle Scholar
• He Y, Le WD, Appel SH. Role of fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp Neurol. 2002;176(2):322–327.
   PubMed Web of Science ®Google Scholar
• García-Domínguez I, Veselá K, García-Revilla J, et al. Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson’s disease. Front Cell Neurosci. 2018;12(398):1–16.
   PubMed Web of Science ®Google Scholar
• Datta I, Ganapathy K, Razdan R, et al. Location and number of astrocytes determine dopaminergic neuron survival and function under 6-OHDA stress mediated through differential BDNF release. Mol Neurobiol. 2018;55(7):5505–5525.
   PubMed Web of Science ®Google Scholar
• Patel D, Jana A, Roy A, et al. Cinnamon and its metabolite protect the nigrostriatum in a mouse model of Parkinson’s disease via astrocytic GDNF. J Neuroimmune Pharmacol. 2019;14(3):503–518.
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Saarma M. CDNF protein therapy in Parkinson’s disease. Cell Transplant. 2019;28(4):349–366.
   PubMed Web of Science ®Google Scholar
• Howells DW, Porritt MJ, Wong JY, et al. Reduced BDNF mRNA expression in the Parkinson’s disease substantia nigra. Exp Neurol. 2000;166(1):127–135.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen S, Liu A, et al. Inhibition of BDNF production by MPP + through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model. Neurosci Lett. 2018;675:133–139.
   PubMed Web of Science ®Google Scholar
• Ben Haim L, Rowitch DH. Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci. 2017;18(1):31–41.
   PubMed Web of Science ®Google Scholar
• Michael LH, Abigail JR, Omar NA, et al. Expression of nestin by neural cells in the adult rat and human brain. PLoS One. 2011;6(4):e18535.
   PubMed Web of Science ®Google Scholar
• Doetsch F, Caillé I, Lim DA, et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97(6):703–716.
   PubMed Web of Science ®Google Scholar
• Rigoglio NN, Barreto RS, Favaron PO, et al. Central nervous system and vertebrae development in horses: a chronological study with differential temporal expression of nestin and GFAP. J Mol Neurosci. 2017;61(1):61–78.
   PubMed Web of Science ®Google Scholar
• Li H, Chen G. In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells. Neuron. 2016;91(4):728–738.
   PubMed Web of Science ®Google Scholar
• Moraga A, Pradillo JM, Cuartero MI, et al. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia. Faseb J. 2014;28(11):4710–4718.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhou A, Xu L, et al. The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience. 2014;269:93–101.
   PubMed Web of Science ®Google Scholar
• Rolls A, Shechter R, London A, et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007;9(9):1081–1088.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Furube E, Morita S, et al. Astrocytic TLR4 expression and LPS-induced nuclear translocation of STAT3 in the sensory circumventricular organs of adult mouse brain. J Neuroimmunol. 2015;278:144–158.
   PubMed Web of Science ®Google Scholar
• Tang AH, Brunn GJ, Cascalho M, et al. Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. J Leukoc Biol. 2007;82(2):282–285.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Lai W, Rivest S, et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007;102(1):37–50.
   PubMed Web of Science ®Google Scholar
• Mariucci G, Pagiotti R, Galli F, et al. The potential role of toll-like receptor 4 in mediating dopaminergic cell loss and alpha-synuclein expression in the acute MPTP mouse model of Parkinson’s disease. J Mol Neurosci. 2018;64(4):611–618.
   PubMed Web of Science ®Google Scholar